about
Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophyTreatment of Cushing disease: overview and recent findingsBone density, structure, and strength in juvenile idiopathic arthritis: importance of disease severity and muscle deficitsGlucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiencyHigh incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapyAn Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyEfficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.Transcriptional regulation of bone and joint remodeling by NFATBone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency.Basic and clinical aspects of osteoporosis in inflammatory bowel disease.Role of teriparatide in treatment of glucocorticoid-induced osteoporosisImproved disease activity with fosdagrocorat (PF-04171327), a partial agonist of the glucocorticoid receptor, in patients with rheumatoid arthritis: a Phase 2 randomized study.Nothing but skin and bone.Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features.Osteoporosis in chronic obstructive pulmonary diseaseRheumatoid arthritis is associated with less optimal hip structural geometryManagement of severe osteoporosis.Quantitative proteomic analysis of dexamethasone-induced effects on osteoblast differentiation, proliferation, and apoptosis in MC3T3-E1 cells using SILAC.Alendronate sodium in the management of osteoporosis.Glucocorticoid-induced osteoporosis: treatment update and review.Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management?Genetic risk factors for decreased bone mineral accretion in children with asthma receiving multiple oral corticosteroid bursts.Clinical development of neridronate: potential for new applications.Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis.Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralizationGlucocorticoid-induced osteoporosis: clinical and therapeutic aspects.Body composition in multiple sclerosis.Expression of HCA2 Receptors in Femoral Epiphysis and Metaphysis of Rats with Dexamethasone-Induced OsteoporosisSkeletal involvement in adult patients with endogenous hypercortisolism.Bone involvement in exogenous hypercortisolism.A case of cushing syndrome diagnosed by recurrent pathologic fractures in a young woman.Glucocorticoids and osteocyte autophagy.The role of liver-derived insulin-like growth factor-I.Strain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice.Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.Variable deficits of bone mineral despite chronic glucocorticoid therapy in pediatric patients with inflammatory diseases: a Glaser Pediatric Research Network study.Clinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoidPediatric inflammatory bowel disease and bone health.Glucocorticoid-induced osteoporosis and parathyroid hormone.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.
P2860
Q24198280-8233B9D7-7B7A-446C-902B-7DB27D63CECAQ24626819-084DCCF2-69FE-4EA3-B0A4-CCA5BD1AF65FQ24653333-1D47B689-6D0C-4625-AB58-855408743FBEQ26821908-233B0714-25FD-4E0B-BBA8-52C00A61E66EQ33618291-7DAE2514-B1B2-473F-91C3-58EA1C027B64Q33743652-BB09DEA1-B461-49B1-B911-20424FE02B04Q33886852-0449710E-EFE7-47D4-962E-0D23945A49EEQ33998768-B98F20E9-BCAA-4B6B-8E6A-A1A89D530645Q34169844-DBDD3EEC-BF53-4B74-B21B-1DEDDD1BA2ECQ34225188-E139EC29-A5EC-4ED7-9A72-8204479092E3Q34235921-AD5C35ED-1EB6-4376-8675-ADD0172968BFQ34553844-355EBEFE-AE30-46F5-8A00-268406E0B20EQ34576635-9800C78A-1B38-4408-94AF-072F97F5339FQ35147216-DFF24FB5-4901-493C-9808-9F7285264B6BQ35173349-1130B165-025A-44FF-9DD4-095C42BEF9E4Q35566318-C7A37833-C42C-424B-9CBB-794D9A90CDA8Q35852252-4DBBD762-6ED3-4899-B740-A62264F576FAQ35865816-37F2D9F9-D9F7-448E-BD46-800575CCA572Q35919111-909CEE50-079A-455F-82D6-1C44CF51204CQ36059394-594C9F6C-28A5-4726-91C8-62EAA8E75F1EQ36146084-B5458940-5B0F-49F1-B767-1C1EEAB5A8CFQ36269204-90320AEF-DD63-4562-A94C-BDC931E81446Q36754978-137D4B1D-D439-43AD-BC69-36ACE3646209Q36873339-7A503766-E11A-4560-82CC-78EE667E23A7Q37003240-700DDBCE-8E19-432B-883A-33D4A3C6E8E8Q37062092-59F4F810-146E-4C9D-AA13-279079E207C9Q37082402-90689690-2081-4CDF-B9AC-9C73B5301B45Q37099608-C273B069-2A93-4C52-8F16-D27A68D24996Q37133892-F4CFF592-AD9C-48B8-8B26-BA54263765F5Q37161922-32FB0725-CD2A-40D7-AFE6-F63D92B4510DQ37192077-5F95A1D7-7AE5-42D0-87A9-F1E2DCEC9531Q37200430-162D6126-52F7-484A-94E7-B8B1EBF6B834Q37381848-ABA40D41-032C-4679-9A91-0A8EDF279F02Q37415046-1023786E-B50D-451F-A3F0-D03027B39150Q37482220-F9B5A153-3A63-429E-803C-92076FD06C55Q37508039-7A8F6D0E-D22D-4AAC-B688-8E904576ECABQ37636900-61EA6EA2-268B-48E3-93AD-4D44A5FC8BCEQ37779425-377B20CB-1BB3-4F5C-913F-D80A94D7590BQ37799488-67040E71-834D-4EB9-9EB1-0B3E1C1AA440Q38015162-DFE10704-3F22-44D3-ACF9-EFDD8AD170E0
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Perspectives on glucocorticoid-induced osteoporosis.
@ast
Perspectives on glucocorticoid-induced osteoporosis.
@en
type
label
Perspectives on glucocorticoid-induced osteoporosis.
@ast
Perspectives on glucocorticoid-induced osteoporosis.
@en
prefLabel
Perspectives on glucocorticoid-induced osteoporosis.
@ast
Perspectives on glucocorticoid-induced osteoporosis.
@en
P2093
P1433
P1476
Perspectives on glucocorticoid-induced osteoporosis.
@en
P2093
Alberto Angeli
Andrea Giustina
Ernesto Canalis
P304
P356
10.1016/J.BONE.2003.11.026
P577
2004-04-01T00:00:00Z